before january 20, 2005, patients requiring this drug as second line treatment for cml were already eligible to apply for assistance under the samaritan fund 在二五年一月二十日之前,需要這種藥物作為慢性骨髓性白血病第二線治療藥物的病人,已合資格申請撒瑪利亞基金的資助。
in ha s knowledge, only about 20 public hospital patients requiring glivec as second line treatment for cml had shouldered the full cost of the drug themselves during the same time period 據(jù)醫(yī)管局所知,同一期間只有約二十名需要加以域作為慢性骨髓性白血病第二線治療藥物的公立醫(yī)院病人自行負(fù)擔(dān)全部藥費(fèi)。
up to the end of 2004, a total of 56 public hospital patients who required glivec as second line treatment for cml have received have been receiving assistance under the fund 截至二四年年底,共有五十六名需要加以域作為慢性骨髓性白血病第二線治療藥物的公立醫(yī)院病人已經(jīng)已一直接受撒瑪利亞基金的資助。